Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy

ClinicalTrials.gov ID: NCT02644668

Public ClinicalTrials.gov record NCT02644668. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 7:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients With Spinal Muscular Atrophy

Study identification

NCT ID
NCT02644668
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cytokinetics
Industry
Enrollment
70 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Reldesemtiv 150 mg Drug
  • Reldesemtiv 450 mg Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 13, 2016
Primary completion
May 30, 2018
Completion
May 30, 2018
Last update posted
Aug 30, 2020

2016 – 2018

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
UCLA Los Angeles California 90095
University of California Irvine Orange California 92868
Pediatric Neuromuscular Clinic Stanford University Palo Alto California 94304
Children's Hospital Colorado Aurora Colorado 80045
Hospital for Special Care New Britain Connecticut 06053
Nemours Childrens Hospital Orlando Florida 32827
Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611
University of Kansas Medical Center Kansas City Kansas 66160
Johns Hopkins Hospital Institute for Clinical and Translational Research Pediatric Clinical Research Unit Baltimore Maryland 21287
Boston Children's Hospital Boston Massachusetts 02115
Washington University School of Medicine St Louis Missouri 63110
Duke University Medical Center Durham North Carolina 27705
The Ohio State University Wexner Medical Center Columbus Ohio 43210
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
The University of Utah, Clinical Neurosciences Center Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02644668, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 30, 2020 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02644668 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →